News Quipt Announces Multi-State Acquisition Adding Approximately $9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration Staff September 11, 2023 Iframe sync Post navigation Previous: Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in BostonNext: Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023 More Stories Fitness News UREVO Announces Black Friday Sale 2026 with Its Biggest Discounts of the Year Staff November 18, 2026 News Pharmaceutical Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Increased Dose of 15 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study Staff November 18, 2026 Cancer Clinical Trial Diagnostics DNA Medicare News Patient Care Pharmaceutical Adaptive Biotechnologies Highlights clonoSEQ’s Central Role in Advancing MRD-Guided Care Across Hematology at ASH 2026 Staff November 18, 2026